BamSEC and AlphaSense Join Forces
Learn More

Synaptogenix Inc.

NASDAQ: SNPX    
Share price (1/8/25): $3.62    
Market cap (1/8/25): $4.907 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 8-K 6 pages Consulting Agreement
12/34/56
EX-10.1
from 8-K 1 page December 16, 2024 Personal and Confidential Re: Amendment No. 4 to Offer Letter 1. Term. Section 2 of the Offer Is Deleted in Its Entirety and Replaced With the Following
12/34/56
EX-10.3
from 8-K 13 pages September 10th, 2024 Strictly Confidential
12/34/56
EX-10.2
from 8-K 30 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 50 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 2 pages June 20, 2024 Personal and Confidential Re: Amendment No. 3 to Offer Letter
12/34/56
EX-10.1
from 8-K 2 pages Amendment No. 3 to Synaptogenix, Inc. 2020 Equity Incentive Plan
12/34/56
EX-10.3
from 8-K 26 pages Cannasoul Analytics Ltd. Amended and Restated Investors' Rights Agreement
12/34/56
EX-10.2
from 8-K 15 pages Collaboration Agreement
12/34/56
EX-10.1
from 8-K 15 pages Share Purchase Agreement
12/34/56
EX-10.1
from 8-K 2 pages June 16, 2023 Personal and Confidential Re: Amendment No. 2 to Offer Letter
12/34/56
EX-10.2
from 10-Q 4 pages ​ Synaptogenix, Inc. ​ First Amendment to Securities Purchase Agreement ​
12/34/56
EX-10.1
from 10-Q 2 pages Synaptogenix, Inc. Amended and Restated Nonemployee Director Compensation Policy
12/34/56
EX-10.3
from 8-K 8 pages A. Finder May From Time to Time, on a Non-Exclusive Basis, Seek to Find and Submit to the Company an Entity (Or Entities) or an Individual (Or Individuals) That Is a Source of Financing for the Company (Herein, a “Candidate”), or an Agent of the Company. Subsequent to Receiving Permission From the Company (Either Verbal or Written), Finder Shall Proceed With Introducing a Candidate(s) to the Company, Which Shall Subsequently Be Memorialized on Exhibit B Hereto, Which Finder May Amend From Time to Time. Candidates for Purposes of This Agreement Include
12/34/56
EX-10.2
from 8-K 30 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 50 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 2 pages Amendment No. 2 to Synaptogenix, Inc. 2020 Equity Incentive Plan
12/34/56
EX-10.2
from 10-Q 2 pages August 4, 2022 ​ Personal and Confidential ​ Re: Amendment to Offer Letter ​ Dear Alan: ​ This Amendment (This “Amendment”) Will Serve to Implement Certain Changes to Your Offer Letter With Synaptogenix Inc. (The “Company”), Dated December 7, 2020 (The “Agreement”). Capitalized Terms Used but Not Defined Herein Shall Have the Meaning Attributed by the Agreement. ​ 1. Term. Section 2 of the Agreement Is Deleted in Its Entirety and Replaced With the Following: ​
12/34/56
EX-10.1
from 10-Q 20 pages ​ Work Order
12/34/56
EX-10.3
from 8-K 15 pages June 14, 2021 Strictly Confidential Mr. Robert Weinstein CFO Synaptogenix, Inc. 1185 Avenue of the Americas 3rd Floor New York, Ny 10036 Dear Mr. Weinstein
12/34/56